Recent deals done by GlaxoSmithKline plc (NYSE:GSK), Electricitie de France SA and Fiat SpA serve as prime examples of the
extreme dealmaking that was talked about at October's Corporate Dealmaker Forum. That was about the time the recession was settling in for the long haul.
A Reuters article highlighted these companies making complex deals that take longer to get done, saying they allow executives to be strategically bold without gorging on leverage, and offer some hope of a pickup in M&A, which has languished even as stock markets have grown more optimistic.
Check out Reuters'
analysis of those companies' dealmaking and see some of the
commentary from last year's CD Forum on extreme dealmaking.
At the forum, Josh King, VP of business development and general counsel at Avvo Inc., posed the question, "How do you balance diligence and speed?"
A post
where we highlighted a Boston Consulting Group Inc. white paper attempts to answer that question. It's titled, "The Clock Is Ticking: Preparing to Seize M&A Opportunities While They Last."
-
Baz HiralalGo to the story
Join Corporate Dealmaker's LinkedIn forum
Juergen Lasowski
And the winners are...
